Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 4 results.
User Information
Export Records
  1. 1.   Bortezomib Sensitizes Human Esophageal Squamous Cell Carcinoma Cells to TRAIL-Mediated Apoptosis via Activation of Both Extrinsic and Intrinsic Apoptosis Pathways
  2. Seki, N.; Toh, U.; Sayers, T. J.; Fujii, T.; Miyagi, M.; Akagi, Y.; Kusukawa, J.; Kage, M.; Shirouzu, K.; Yamana, H.
  3. Molecular Cancer Therapeutics. 2010, Jun; 9(6): 1842-1851.
  1. 2.   Bortezomib Sensitizes Human Renal Cell Carcinomas to TRAIL Apoptosis through Increased Activation of Caspase-8 in the Death-Inducing Signaling Complex
  2. Brooks, A. D.; Jacobsen, K. M.; Li, W. Q.; Shanker, A.; Sayers, T. J.
  3. Molecular Cancer Research. 2010, May; 8(5): 729-738.
  1. 3.   The proteasorne inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP
  2. Sayers, T. J.; Brooks, A. D.; Koh, C. Y.; Ma, W. H.; Seki, N.; Raziuddin, A.; Blazar, B. R.; Zhang, X.; Elliott, P. J.; Murphy, W. J.
  3. Blood. 2003 102(1): 303-310.
  1. 4.   TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with edar and is expressed in embryonic skin and hair follicles
  2. Kojima, T.; Morikawa, Y.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Senba, E.; Kitamura, Y.
  3. Journal of Biological Chemistry. 2000 275(27): 20742-20747.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel